Navigation Links
Are intravenous treatments safe? New research raises doubts
Date:8/31/2009

German scientists have identified a serious and previously misunderstood contaminant that brings the safety and efficacy of intravenous treatments into question. In a report published in the September 2009 issue of the Journal of Leukocyte Biology (http://www.jleukbio.org), they show how a common intravenous treatment used to boost blood pressure in ailing patients also contains substances called "advanced glycation end products," which trigger inflammation. These substances result from reactions that occur among the various proteins (called "posttranslational modification") within the intravenous fluid after it has been formulated for use. This study directly challenges today's prevalent belief that advanced glycation end products are not contaminants.

"Improving the quality of infusion solutions by accounting for posttranslational modification of proteins could lead to better clinical outcomes for patients, such as those treated solutions containing albumin," said Angelika Bierhaus, senior scientist and co-study author from the University of Heidelberg in Germany.

To make their discovery, Bierhaus and colleagues detected advanced glycation end products in several currently available albumin infusion solutions and injected separate groups of mice with solutions containing both high and low amounts of this substance. The mice receiving the high levels of advanced glycation end products experienced significantly higher inflammation and death rates than the mice receiving solutions with low levels of advanced glycation end products. This suggests that screening infusion solutions for posttranslational protein modifications and then removing the compounds may improve patient outcomes, especially treatments requiring albumin infusions.

"It is always difficult to learn that what was once thought safe might have more risk than previously appreciated, especially when it relates to treatments mea
'/>"/>

Contact: Cody Mooneyhan
cmooneyhan@faseb.org
301-634-7104
Federation of American Societies for Experimental Biology
Source:Eurekalert

Page: 1 2

Related medicine news :

1. FDA Clears MDN-CGS(R) Intravenous Insulin Dosing Software
2. BioCryst Reports Positive Results From a Phase 2 Study of Intravenous Peramivir for Outpatient Influenza
3. Most Important Factors Driving Usage of Antibiotics in the ICU Setting are Availability in Intravenous Formulation, Activity Against Key Gram Negative Pathogens, Drug Interactions and Bactericidal Activity
4. New form of intravenous iron treats anemia in chronic kidney disease patients on dialysis
5. Number of cardiovascular risk factors could determine safety of intravenous gammaglobulin treatment
6. New Bill Offers Medicare Reimbursement Fix for Intravenous Immune Globulin
7. Availability in Both Intravenous and Oral Formulation is a Leading Drug Attribute Surveyed Physicians Prefer for the Treatment of Urinary Tract Infections in the Hospital Setting
8. Intravenous Immune Biologics Will Suffer from the Pending Shift in Coverage from the Medical to the Pharmacy Benefit
9. Drug-free treatments offer hope for older people in pain
10. Updated Brochure on Gynecologic Cancer Treatments Now Available
11. Plastic Surgery 2007: Where Truth Behind Emerging Cosmetic Treatments Meets Amazing Reconstructive Advances
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/24/2015)... The 1975 have had an intense ... globe to theaters, festivals and TV performances. Now that they’ve ... their label, Dirty Hit Records, to provide clean drinking water ... launched Cadence & Cause website, this four-piece has ... and a signed photo card. Entries from this sweepstakes ...
(Date:4/24/2015)... The first step to transforming one’s ... For meditation and yoga teacher Stine Koppernæs, meditation and ... tools that allow her to experience more peace and ... a teacher since 2006, and through the years she ... being. , “I love sharing this way of finding ...
(Date:4/24/2015)... 24, 2015 Carinsurancequotesinfo.com has released a ... explaining how to qualify for auto insurance ... qualify for auto insurance online, without having to follow ... that single parents can reduce their auto insurance expenses. ... and properly explained. , Clients can now visit ...
(Date:4/24/2015)... (PRWEB) April 24, 2015 Integrative ... two key pathways: immunity and cognition. , A ... Glutathione, helps set ProThrivers™ Wellness Flavonoid Complex apart ... the combination of ingredients to support antioxidation versus ... It unites curcumin, green tea extract, Resveratrol, Alpha-Glycosyl ...
(Date:4/24/2015)... (PRWEB) April 24, 2015 “Kind,” “selfless,” ... were among the ways Denise Weiner described pediatric oncology ... cared for her daughter, Alexa, during her five-year battle ... resections, a bone marrow transplant and numerous experimental treatments, ... to visit Alexa when she was not in the ...
Breaking Medicine News(10 mins):Health News:Internationally Recognized British Indie Rock Outfit The 1975 Partner with Cadence & Cause to Provide Clean Drinking Water to Those in Need 2Health News:Auto Insurance Discounts for Single Parents - How to Qualify for Low Rates 2Health News:Integrative Therapeutics Introduces Two ProThrivers™ Wellness Supplements with Specialty Ingredients from Kyowa Hakko USA 2Health News:Integrative Therapeutics Introduces Two ProThrivers™ Wellness Supplements with Specialty Ingredients from Kyowa Hakko USA 3Health News:Integrative Therapeutics Introduces Two ProThrivers™ Wellness Supplements with Specialty Ingredients from Kyowa Hakko USA 4Health News:CURE™ Magazine Names Pediatric Nurse Laura Vasquez from Children’s Hospital Los Angeles As Extraordinary Healer™ of 2015 2Health News:CURE™ Magazine Names Pediatric Nurse Laura Vasquez from Children’s Hospital Los Angeles As Extraordinary Healer™ of 2015 3Health News:CURE™ Magazine Names Pediatric Nurse Laura Vasquez from Children’s Hospital Los Angeles As Extraordinary Healer™ of 2015 4
... (HealthDay News) -- Children who are successfully treated for ... severe gastrointestinal problems down the road, a new study ... Francisco analyzed the self-reported gastrointestinal (GI) problems of 14,358 ... for cancers such as lymphoma, leukemia, brain tumors or ...
... from the National Institutes of Health (NIH) to help ... shown effective in mice toward clinical trials in humans. ... Sanfilippo Syndrome B, is a lysososmal storage disease caused ... MPS IIIB appear normal at birth, but develop severe, ...
... number of cases of adenocarcinoma of the esophagus (or gullet) ... new ways of treatment are improving the outlook for patients. ... ( Dtsch Artzebl Int 2011; 108[18]: 313𔃇), Angelika Behrens ... treatment. The main cause of this cancer is reflux ...
... led by Trinity College Dublin that aims ... been selected for grant funding of 6 million by ... consortium NILVAD*, comprising 18 European universities, hospitals and pharmaceutical ... the treatment of Alzheimer,s disease (AD). Trinity ...
... be older, better-educated and divorced, widowed or separated, research ... University of Nottingham found that emotional factors and mental ... by women. And they also discovered that rehabilitation ... their crime can intensify their feelings of guilt and ...
... gut flora is believed to trigger obesity. In the same way, ... be the case in tests on rats. Daily intake ... Lactobacillus plantarum HEAL19, appears to be able to prevent ... were given this specific lactic acid bacterium from their time in ...
Cached Medicine News:Health News:Childhood Cancer Therapies Tied to Gastrointestinal Issues 2Health News:NIH grant for the move toward clinical trials targeting the lysosomal storage disease MPSIIIB 2Health News:Clinical trials for new Alzheimer's disease treatment to be awarded European Commission €6m funding 2Health News:Research study reveals profile for female drunk-drivers 2Health News:Research study reveals profile for female drunk-drivers 3Health News:Healthy gut flora could prevent obesity 2
(Date:4/24/2015)... N.J. , April 24, 2015  IGI Laboratories, ... based specialty generic pharmaceutical company, announced the ... ET on Tuesday, April 28, 2015 to discuss the ... you to listen to the call by dialing 1-888-346-3479. ... 1-855-669-9657.  Participants should ask to be joined into the ...
(Date:4/24/2015)... 2015 Boston Scientific Corporation (NYSE: BSX ) ... Annual Healthcare Conference on May 6 in ... vice president and chief financial officer, and Susie Lisa ... question and answer session regarding the company with the host ... webcast of the presentation and question and answer session will ...
(Date:4/24/2015)... The National Institute of Allergy and ... of Health [NIH])  provided grants totaling more than ... development of diagnostic tests for antibiotic-resistant bacteria . ... health facilities , the NIAID and other government ... effective tests using alternative methods to traditional culturing.   ...
Breaking Medicine Technology:Boston Scientific To Participate In The Deutsche Bank 40th Annual Healthcare Conference 2Kalorama: NIAID Rewards HAI Innovators with Grants 2Kalorama: NIAID Rewards HAI Innovators with Grants 3Kalorama: NIAID Rewards HAI Innovators with Grants 4
... Primary Endpoint of the Trial to Be Clarified ... Arbios Systems, Inc.,(OTC Bulletin Board: ABOS) announced today ... U.S. Food and Drug Administration ("FDA") of,an Investigational ... for SEPET(TM), Arbios, extracorporeal (outside the body) artificial,liver ...
... Feb. 21 Accumetrics, Inc. a privately-held,medical device ... tests that,measure patient response to antiplatelet drugs, announced ... Series D financing. The syndicate was led by,Arnerich ... Also participating,in the round were previous investors: Essex ...
Cached Medicine Technology:Arbios Receives Conditional Approval from the FDA to Initiate Pivotal Clinical Trial for SEPET(TM) 2Arbios Receives Conditional Approval from the FDA to Initiate Pivotal Clinical Trial for SEPET(TM) 3Arbios Receives Conditional Approval from the FDA to Initiate Pivotal Clinical Trial for SEPET(TM) 4Accumetrics Announces $28.8 Million Financing and Initiation of Pivotal Clinical Trial 2
Minimizes imperfections and reduces the visible appearance of cellulite and stretch marks. This formula refines uneven skin texture and improves skin firmness and elasticity to leave you with skin yo...
The fat loss formula's key ingredient of 2.0% aminophylline works by penetrating deep into the skin where it causes the body fat cells to shrink, resulting in up to 2 inches of body fat loss....
... This new Suction Massage System has ... prone areas, such as thighs, buttocks and ... massaging the lymph system, mobilizing excess fluids ... naturally. Initially, we recommend using CELLUSSAGE daily, ...
... the first and only class ... revolutionary elos combined energy technology ... Infrared Light plus tissue ... reduce the appearance of cellulite ...
Medicine Products: